Related Experiment Video

Updated: Aug 19, 2026

A Minimally Invasive Method for Intratracheal Instillation of Drugs in Neonatal Rodents to Treat Lung Disease
04:21

A Minimally Invasive Method for Intratracheal Instillation of Drugs in Neonatal Rodents to Treat Lung Disease

Published on: August 4, 2021

[Treatment of acute rhinitis in neonates and infants]

V S Minasian, M G Bondarenko

    Vestnik Otorinolaringologii
    |February 9, 2005
    PubMed

    Insights

    Physiomer Baby effectively treats acute rhinitis (AR) in infants by clearing nasal passages, enhancing other medications, and speeding recovery. This saline nasal spray offers a safe and efficient method for infant nasal hygiene.

    Area of Science:

    • Pediatric Otolaryngology
    • Nasal Physiology and Pathology
    • Pharmacology of Nasal Treatments

    Context:

    • Acute rhinitis (AR) is a common condition in infants, necessitating safe and effective treatment options.
    • Current therapeutic approaches for infant AR require evaluation for efficacy and ease of administration.
    • Nasal hygiene plays a crucial role in managing upper respiratory conditions in young children.

    Purpose:

    • To review current perspectives on the management of acute rhinitis in infants.
    • To present clinical experience with Physiomer Baby in treating acute rhinitis in 30 infants.
    • To evaluate the efficacy of Physiomer Baby in eradicating inflammation and facilitating other nasal treatments.

    Summary:

    • Combined therapy including Physiomer Baby demonstrated rapid inflammation reduction in infants with AR.
    • Physiomer Baby effectively removes nasal crusts and discharge, preparing the nasal mucosa for enhanced medication absorption.
    • The spray's design ensures optimal nasal cavity lavage and ease of use in infant nostrils.

    Impact:

    • Physiomer Baby improves the effectiveness of concurrent nasal medications, leading to accelerated recovery in infants.
    • The product's design facilitates optimal drug delivery and patient comfort during treatment.
    • This approach offers a valuable non-pharmacological adjunct for managing infant acute rhinitis.

    More Related Videos

    Intratracheal Instillation of Stem Cells in Term Neonatal Rats04:27

    Intratracheal Instillation of Stem Cells in Term Neonatal Rats

    Published on: May 4, 2020

    Related Concept Videos

    Drugs Used in Upper Respiratory Disorders: Overview01:16

    Drugs Used in Upper Respiratory Disorders: Overview

    Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
    Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
    Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

    Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

    Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
    Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...
    Acute Respiratory Failure-V01:29

    Acute Respiratory Failure-V

    The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
    Ensure that patients are monitored continuously for their response to therapy, including changes in...
    Epistaxis01:30

    Epistaxis

    Epistaxis, or nosebleeds, occurs when small, swollen blood vessels in the nasal mucous membrane rupture. Typically, the anterior septum is the primary site of occurrence.
    Etiology
    Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
    Respiratory Syncytial Virus Disease01:29

    Respiratory Syncytial Virus Disease

    Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
    Pneumonia IV: Management01:28

    Pneumonia IV: Management

    The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
    Bacterial Pneumonia Treatment
    For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: